New publication on the kinetics of homoarginine supplementation
27 May 2022, by Kroemer
Our colleagues at the University Medical Centre (UKE) study the impact of homoarginine supplementation on the cardiovascular risk. In a subproject, we studied the kinetics of the amino acid homoarginine and developed an optimized dosing scheme for homoarginine supplementation. The work was led by Christine Kleist from our team.